ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1166

Biomarkers Associated with Left Atrial Structure and Function in Individuals with Psoriasis

Julie Borchsenius1, Maria Dons2, Morten Sengeløv3, Flemming Olsen4, Caroline Espersen4, Kristoffer Skaarup3, Mats Lassen4, Niklas Johansen4, Filip Davidovski3, Manan Pareek4, Brittany Weber5, Claus Zachariae6, Lone Skov6 and Tor Biering-Sørensen3, 1CTCPR / Center for translational cardiology and pragmatic research trials, Charlottenlund, Denmark, 2Copenhagen University Hospital Gentofte, Copenhagen, Hovedstaden, Denmark, 3Center for Translational Cardiology and Pragmatic Randomized Trials, Dep. of Cardiology, Copenhagen University Hospital - Gentofte, Copenhagen, Hovedstaden, Denmark, 4CTCPR / Center for translational cardiology and pragmatic research trials, Copenhagen, Denmark, 5Brigham and Women's Hospital, DEDHAM, MA, 6Dep. of Dermatology and Allergy, Copenhagen University Hospital – Herlev & Gentofte, Copenhagen, Hovedstaden, Denmark

Meeting: ACR Convergence 2025

Keywords: Autoinflammatory diseases, Biomarkers, Dermatology, Heart disease, risk assessment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1147–1190) Miscellaneous Rheumatic & Inflammatory Diseases Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Individuals with psoriasis are at increased risk of developing heart disease. Echocardiographic parameters of impaired left atrial (LA) strain (Peak atrial contraction and longitudinal strain (PACS and PALS)) and volume index (LAVi) are associated with increased risk of heart disease. Whether cardiac and inflammatory biomarkers are associated with left atrial impairment in adults with psoriasis is unknown. The aim of this study was to assess whether plasma levels of high-sensitivity C-reactive protein (hsCRP), high-sensitivity troponin I (hsTnI) and pro-brain natriuretic peptide (proBNP) were associated with LA structure and function in adults with psoriasis.

Methods: This was a cross-sectional analysis of a prospective cohort study of 1,010 participants with psoriasis who underwent echocardiographic examination and had blood samples analyzed from 2021-2024. Those without available measurements of hsCRP (n=27), TnI (n=5) or proBNP (n=17), LA strain (n=23) or LAVi (n=11) were excluded. The population was stratified according to hsCRP, hsTnI and proBNP tertiles, respectively. We used ANOVA, Pearson’s Chi2-test, Kruskal-Wallis test, linear regression and cubic spline models as appropriate to assess the associations between biomarkers, cardiac risk factors and measures of LA structure and function. Biomarkers were logarithmically transformed for the linear regression analyses. In multivariable analyses, models were adjusted for sex, age, package years, BMI >30, hypertension, hypercholesterolemia, diabetes mellitus, chronic kidney disease, ischemic heart disease, heart failure, atrial fibrillation and psoriasis treatment.

Results: We included 927 adults with psoriasis (mean age 54.0 years, 46.5 % women). In the entire cohort, median hsCRP was 1.1 mg/l (IQR 0.5-2.7), median hsTnI was 3.0 ng/l (IQR 1.2-6.0) and the median proBNP was 7.6 ng/l (4.2-14.3). The participants in the highest tertile groups of all three biomarkers were overall older, had more package years and a higher prevalence of hypertension. Furthermore, the highest hsCRP group >1.73 mg/l were predominantly women, had higher BMI and were less physically active. The highest TnI group >5 ng/l were predominantly men, had a higher prevalence of moderate-to-severe psoriasis, and cardiovascular disease was more prevalent. The proBNP-group >11.5 ng/l had more women and a higher prevalence of cardiovascular disease. In univariable analyses, higher levels of hsCRP were associated with lower PALS, while higher levels of TnI and proBNP were associated with lower PACS and PALS and higher LAVi. In multivariable analyses, higher levels of TnI and proBNP remained significantly associated with lower PACS and PALS and higher LAVi. (Figure)

Conclusion: In a sample of adults with psoriasis, higher levels of TnI and proBNP were associated with impaired LA structure and function. Given the known association between LA dysfunction and heart disease, these biomarkers may identify individuals with psoriasis at increased risk of cardiac disease.

Supporting image 1Cubic spline models analyzing the association between biomarkers and echocardiographic measures of left atrial strain and volume index.


Disclosures: J. Borchsenius: None; M. Dons: Karen Elise Jensens Foundation, 5, Lundbeck Foundation, 5; M. Sengeløv: None; F. Olsen: None; C. Espersen: None; K. Skaarup: None; M. Lassen: None; N. Johansen: None; F. Davidovski: None; M. Pareek: AstraZeneca, 1, 6, Bayer, 1, 6, Boehringer-Ingelheim, 6, Janssen, 1, 6, Novo Nordisk, 5, 6, The Danish Heart Foundation, 5; B. Weber: Bristol-Myers Squibb(BMS), 2, Kiniksa Pharmaceuticals, 2, Novo nordisk, 2, Novo Nordisk, 2, Oruka, 2; C. Zachariae: None; L. Skov: AbbVie/Abbott, 1, 6, Almirall, 1, 5, Bristol-Myers Squibb(BMS), 1, 5, 6, Eli Lilly, 1, 6, Janssen, 1, 5, 6, Novartis, 1, Pfizer, 6, Sanofi, 1, 5, 6, stada, 1, takeda, 1, 6, UCB, 1, 5, 6; T. Biering-Sørensen: Amgen, 2, AstraZeneca, 5, 6, Bayer, 6, Boston Scientific, 5, CSL Seqirus, 2, GE Healtcare, 5, 6, GlaxoSmithKlein(GSK), 2, 5, 6, IQVIA, 2, Novartis, 5, 6, Novo Nordisk, 2, 5, Parexel, 2, Pfizer, 5, Sanofi Pasteur, 2, 5, 6.

To cite this abstract in AMA style:

Borchsenius J, Dons M, Sengeløv M, Olsen F, Espersen C, Skaarup K, Lassen M, Johansen N, Davidovski F, Pareek M, Weber B, Zachariae C, Skov L, Biering-Sørensen T. Biomarkers Associated with Left Atrial Structure and Function in Individuals with Psoriasis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/biomarkers-associated-with-left-atrial-structure-and-function-in-individuals-with-psoriasis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/biomarkers-associated-with-left-atrial-structure-and-function-in-individuals-with-psoriasis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology